Get Silicon Valley Top 1000 Contacts List

Lern more

Vaxcyte

Verified by our team

  • Biotechnology
Linkedin Twitter Facebook

Vaxcyte is a vaccine innovation company focused on developing broad-spectrum conjugate and protein vaccines to prevent and treat bacterial infectious diseases. Using advanced synthetic techniques and the XpressCF™ platform, Vaxcyte aims to create high-fidelity vaccines with enhanced immunological benefits, with candidates like VAX-24 for pneumococcal disease and VAX-A1 for Group A Strep.

Vaxcyte Highlights:

  • Vaxcyte annual revenue is $575.2M.
  • Vaxcyte total funding is $1.5B.
  • Vaxcyte headquartered in San Carlos, California.
  • Vaxcyte number of employees is 380.

    • Overview

    • Website: vaxcyte.com
    • Headquarters: San Carlos, California
    • Employees: 380
    • Founded: 2013
    • Email: info@vaxcyte.com
    • Funding: $1.5B
    • Revenue: $575.2M
    • Valuation: n/a

    Contacts

    Annette Makarewycz

    President
    Linkedin
    • Email: ***@vaxcyte.com
    Buy the List to Unlock Contacts

    Similar companies

    Frequently Asked Questions related to Vaxcyte

    Vaxcyte is located in San Carlos, California.
    Yes, Vaxcyte is a Silicon Valley company.
    Vaxcyte total funding is 1.5B.
    Vaxcyte revenue is 575.2M.
    Vaxcyte’s number of employees is 380.
    Vaxcyte’s CEO name is Annette Makarewycz.
    Vaxcyte was founded in 2013.
    Vaxcyte’s contact email is info@vaxcyte.com.

    Follow Silicon Valley Journals

    Awarded by

    corporate vision magazine

    © Copyright 2022-2024 Silicon Valley Journals. All rights reserved.

    Fundings

    Quick links

    Company

    © Copyright SVJ Media Ltd., 71-75 Shelton Street. Covent Garden. London, GB WC2H 9JQ